Enveda reads natures chemistry with AI - the platform is built on it, and it finds new medicines ~4x faster than the industry standard. We reached unicorn status on a $150M Series D, our first medicines are now in clinical trials with a deep pipeline right behind them, and were backed by Sanofi, Lux Capital, and Baillie Gifford, with former Pfizer R&D chief Mikael Dolsten on the board.

The role

As a Sr. Clinical Development Director at Enveda, youll have two core roles: working with the VP of clinical development on asset strategy; and hands on ownership of key study activities. This is a leadership role without direct reports - you will be a subject matter expert for the asset, work closely with a range of team members (e.g. translational, clinical development, operations, statistics) to help drive efficiencies and successes of the programs. In the first year of this role, there are several key activities that you will be involved with or leading: helping review the data from Enveda’s first phase 2 study, while leading the expansion of this asset to new areas. This is a high impact opportunity where youll influence the outcome of Enveda’s lead asset, ENV-294, while collaborating with some of the brightest minds in the industry.